Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$99.50

0.71 (0.72%)

10:55
08/20/18
08/20
10:55
08/20/18
10:55

AbbVie put volume heavy and directionally bearish

Bearish flow noted in AbbVie with 7,257 puts trading, or 2x expected. Most active are Nov-18 92.5 puts and Nov-18 95 puts, with total volume in those strikes near 4,600 contracts. The Put/Call Ratio is 1.98, while ATM IV is up nearly 2 points on the day. Earnings are expected on October 26th.

  • 12

    Sep

ABBV AbbVie
$99.50

0.71 (0.72%)

06/22/18
FBCO
06/22/18
NO CHANGE
Target $89
FBCO
Underperform
AbbVie most exposed to biosimilar risk, says Credit Suisse
Credit Suisse analyst Vamil Divan reiterated an Underperform rating on AbbVie after the FDA further ramped up its focus on biosimilars. In a research note to investors, Divan said he was "intrigued" by the FDA's decision to withdraw its September 2017 Draft Guidance focused on evaluating analytical similarity with biosimilars, and believes the agency will release "more reasonable" guidance in the coming months that will expedite the approval and uptake of biosimilars. AbbVie is most exposed to Biosimilar risk, Divan says, with Humira accounting for about 60% of its total net present value, and is cautious on AbbVie's outlook in front of biosimilar competition in the EU later this year and in the U.S. by 2023.
07/24/18
SBSH
07/24/18
NO CHANGE
SBSH
Buy
Citi says Myovant may have $102 upside if relugolix priced at parity to elagolix
After AbbVie (ABBV) and Neurocrine Biosciences (NBIX) announced that the FDA approved elagolix and Neurocrine said the list price has been set at $28 per day, Citi analyst Robyn Karnauskas noted that she currently models Myovant Sciences' (MYOV) relugolix priced at $10 per day. Modeling relugolix pricing at parity to elagolix and assuming a gross-to-net of 100% would lead to a fair value estimate for Myovant of $146, or the equivalent of $102 of upside from her current price target of $44, Karnauskas stated. The analyst, who models a split market between relugolix and elagolix in endometriosis, keeps a Buy rating on Myovant shares.
07/27/18
PIPR
07/27/18
NO CHANGE
Target $100
PIPR
Neutral
Worries about AbbVie's Humira keep Piper Jaffray on sidelines
Piper Jaffray analyst Christopher Raymond said he finds "little to quibble with" in AbbVie's Q2 report, but also noted that while its FY18 EPS guidance was raised, its revenue guidance actually came down slightly. Raymond, who continues to worry that consensus does not fully factor in the extent of ex-U.S. Humira pressure or the further pressure from co-pay accumulator programs in the U.S., prefers to stay on the sidelines and keeps a Neutral rating on the shares. He also lowered his price target on AbbVie to $100 from $105.
08/08/18
HCWC
08/08/18
NO CHANGE
Target $44
HCWC
Buy
ObsEva price target raised to $44 from $30 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for ObsEva (OBSV) to $44 based on the disclosed pricing for AbbVie's (ABBV) Orilissa, the fgonadotropin-releasing hormone receptor antagonist for endometriosis and uterine fibroids. ObsEva management had previously guided to the cost of GnRH receptor antagonist therapy at $15 per day, about $450 per month, and the proposed monthly cost of Orilissa at $845 "appears to be comfortably above this level," Selvaraju tells investors in a research note. As such, the analyst elected to revise his pricing assumptions upward for ObsEva's linzagolix to reflect a daily cost of $25. He keeps a Buy rating on ObsEva shares.

TODAY'S FREE FLY STORIES

KTOS

Kratos Defense

$20.70

0.28 (1.37%)

13:25
05/23/19
05/23
13:25
05/23/19
13:25
Options
Kratos Defense call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
05/23/19
05/23
13:25
05/23/19
13:25
General news
Treasury's $11 B 10-year TIPS sale was surprisingly solid »

Treasury's $11 B…

ACAD

Acadia

$24.82

-0.29 (-1.15%)

, ALKS

Alkermes

$24.22

-0.83 (-3.31%)

13:25
05/23/19
05/23
13:25
05/23/19
13:25
Conference/Events
JPMorgan biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Fye,…

ACAD

Acadia

$24.82

-0.29 (-1.15%)

ALKS

Alkermes

$24.22

-0.83 (-3.31%)

ITCI

Intra-Cellular

$13.34

0.26 (1.99%)

NBIX

Neurocrine

$78.45

-1.42 (-1.78%)

SAGE

Sage Therapeutics

$174.50

-0.5 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

  • 27

    Sep

ICPT

Intercept

$85.25

-0.98 (-1.14%)

, RHHBY

Roche

$0.00

(0.00%)

13:21
05/23/19
05/23
13:21
05/23/19
13:21
Recommendations
Intercept, Roche analyst commentary at RBC Capital »

RBC sees…

ICPT

Intercept

$85.25

-0.98 (-1.14%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

  • 03

    Jun

  • 20

    Jun

  • 20

    Jun

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
05/23/19
05/23
13:17
05/23/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
05/23/19
05/23
13:16
05/23/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$13.72

-0.335 (-2.38%)

13:15
05/23/19
05/23
13:15
05/23/19
13:15
Options
Tencent put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,135.50

-17.61 (-1.53%)

, GOOG

Alphabet

$1,130.85

-19.65 (-1.71%)

13:13
05/23/19
05/23
13:13
05/23/19
13:13
Hot Stocks
Google announces integration with food delivery service providers »

In a post to a corporate…

GOOGL

Alphabet Class A

$1,135.50

-17.61 (-1.53%)

GOOG

Alphabet

$1,130.85

-19.65 (-1.71%)

UBER

Uber

$40.51

-0.58 (-1.41%)

GRUB

GrubHub

$65.02

-3.52 (-5.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

  • 19

    Jun

  • 19

    Jun

  • 27

    Jun

  • 27

    Oct

VRNT

Verint

$56.01

-5.2 (-8.50%)

13:11
05/23/19
05/23
13:11
05/23/19
13:11
Hot Stocks
Verint says short seller report 'inaccurate and deliberately misleading' »

Verint Systems issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 20

    Jun

13:08
05/23/19
05/23
13:08
05/23/19
13:08
General news
10-Yr TIPS Auction Coupon Rate data reported »

10-Yr TIPS Auction Coupon…

13:08
05/23/19
05/23
13:08
05/23/19
13:08
General news
10-Yr TIPS Auction Total Amount data reported »

10-Yr TIPS Auction Total…

M

Macy's

$21.36

-0.45 (-2.06%)

13:05
05/23/19
05/23
13:05
05/23/19
13:05
Options
Macy's call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEBK

Wellesley Bancorp

$35.05

(0.00%)

13:02
05/23/19
05/23
13:02
05/23/19
13:02
Hot Stocks
Wellesley Bancorp raises quarterly cash dividend 9.1% to 6c per share »

Wellesley Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JYNT

Joint Corp.

$16.00

-1.5 (-8.57%)

13:02
05/23/19
05/23
13:02
05/23/19
13:02
Recommendations
Joint Corp. analyst commentary at DA Davidson »

Joint Corp. weakness on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

AMZN

Amazon.com

$1,812.11

-45.63 (-2.46%)

12:57
05/23/19
05/23
12:57
05/23/19
12:57
Periodicals
Amazon developing wrist device that can read human emotions, Bloomberg says »

Amazon is working on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 24

    Jun

JYNT

Joint Corp.

$16.00

-1.5 (-8.57%)

12:56
05/23/19
05/23
12:56
05/23/19
12:56
Periodicals
Joint Corp. mentioned cautiously by Seeking Alpha contributor »

In a short report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

ESV

Ensco Rowan

$8.98

-0.87 (-8.83%)

12:55
05/23/19
05/23
12:55
05/23/19
12:55
Options
Ensco put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
05/23/19
05/23
12:55
05/23/19
12:55
Conference/Events
Federal Reserve Bank of Dallas to hold a conference »

Atlanta Federal Reserve…

12:55
05/23/19
05/23
12:55
05/23/19
12:55
Conference/Events
JPMorgan biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Fye,…

INTU

Intuit

$241.77

-5.75 (-2.32%)

12:50
05/23/19
05/23
12:50
05/23/19
12:50
Hot Stocks
Senators ask Intuit about reports of misleading taxpayers on free options »

Senator Elizabeth Warren…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

INTU

Intuit

$241.84

-5.68 (-2.29%)

12:47
05/23/19
05/23
12:47
05/23/19
12:47
Periodicals
TurboTax's 'discount' tricks military into paying to file taxes, ProPublica says »

Intuit, the maker of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

12:45
05/23/19
05/23
12:45
05/23/19
12:45
General news
Breaking General news story  »

San Francisco Federal…

12:45
05/23/19
05/23
12:45
05/23/19
12:45
General news
Breaking General news story  »

Richmond Federal Reserve…

12:45
05/23/19
05/23
12:45
05/23/19
12:45
General news
Breaking General news story  »

Dallas Federal Reserve…

12:45
05/23/19
05/23
12:45
05/23/19
12:45
General news
Breaking General news story  »

Atlanta Federal Reserve…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.